120
Views
56
CrossRef citations to date
0
Altmetric
Original Article

HIV Risk Behaviors Associated with the Injection Process: Multiperson Use of Drug Injection Equipment and Paraphernalia in Injection Drug User Networks

, , , , , , , , , , , , & show all
Pages 2403-2423 | Published online: 03 Jul 2009

References

  • Beardsley M., Clatts M. C., Deren S., Davis W. R., Tortu S. Homelessness and HIV risk behaviors in a sample of New York City drug injectors. AIDS Public Policy 1992; 7(3)162–169
  • Bourgois P. Participant Observation Study of Indirect Paraphernalia Sharing/HIVRisk in a Network of Heroin Injectors. San Francisco State University, San Francisco, CA 1995
  • Handbook on Risk of AIDS: Injection Drug Users and Sexual Partners, B. S. Brown, G. M. Beschner. Greenwood Press, Westport, CT 1993
  • CDC/CSAT/NIDA. HIV/AIDS Prevention Bulletin April 19, 1993
  • Chitwood D. D., McCoy C. B., Comerford M. Risk behaviors of intravenous cocaine users: Implications for intervention. AIDS and Intravenous Drug Use: Future Directions for Community-Based Prevention Research, C. G. Leukefeld, R. J. Battjes, Z. Amsel. Superintendent of Document, US GPO, Washington, DC 1990; 120–134, [NIDA Research Monograph 93, DHHS Publication (ADM) 90–1627].
  • Clatts M. C. The Needle Hygiene Project: Preliminary Ethnographic Findings from Harlem. Paper presented at the NIDA Cooperative Agreement Steering Committee Meeting. 1993. Bethesda, MD November 16, 1993a
  • Clatts M. C. Poverty, drugs, and AIDS: Converging lines in the life stories of women in Harlem. Wings of Gauze: Women of Color and the Experience of Health and Illness, B. Bair, S. Cayleff. Wayne State University Press, Detroit, MI 1993b; 328–339
  • Clatts M. C., Beardsley M., Davis W. R., Deren S., Tortu S. Homelessness and Risk Behavior among U.S. Drug Injectors: Implications for Prevention Policy. Poster presented at the VIII International Conference on AIDS. 1992. Amsterdam July 19– 24, 1992
  • Clatts M. C., Davis W. R., Deren S., Goldsmith D. S., Tortu S. AIDS risk behavior among drug injectors in New York City: Critical gaps in prevention policy. Global AIDS Policy, D. Feldman. Bergin and Garvey, Westport, CT 1994; 215–235
  • Clatts M. C., Marshall P. A. (1992) AIDS and Ethnography: Ethical Issues. Paper presented at the Annual Meeting of the American Anthropological Association. 1992. San Francisco, CA
  • Des Jarlais D. C., Hagan H., Friedman S. R., Friedmann P., Goldberg D., et al. Maintaining low HIV seroprevalence in populations of injection drug users. JAMA 1995; 274: 1226–1231
  • Feldman H. W., Biernacki P. The ethnography of needle sharing among intravenous drug users and implications for public policies and intervention strategies. Needle Sharing among Intravenous Drug Abusers: National and International Perspectives, R. J. Battjes, R. W. Pickens. Superintendent of Documents, US GPO, Washington, DC 1988; 28–39, [NIDA Research Monograph 80, DHHS Publication (ADM) 89–1567].
  • Friedland G. H., Harris C., Butkus-Small C., et al. Intravenous drug abusers and the acquired immune deficiency syndrome. AIDS Arch. Intern. Med. 1995; 145: 1413–1417
  • Groseclose S. L., Weinstein B., Jones T. S., Valleroy L. A., Fehrs L. J., Kassler W. J. Impact of increased legal access to needles and syringes on practices of injecting drug users and policy officers–Connecticut, 1992–1993. J. Acquired Immune Deficiency Syndromes Hum. Retrovirol. 1995; 10: 82–89
  • Grund J. P. C., et al. Syringe-mediated drug sharing among injecting drug users: Patterns, social context and implications for transmission of blood-borne pathodgens. Soc. Sci. Med. 1996; 42(5)691–703
  • Grund J. P. C., Kaplan N., Adriaans N., Blanken P. Drug sharing and HIV transmission risks: The practice of frontloading in the Dutch injecting drug user population. J. Psychoactive Drugs 1991; 23(1)1–10
  • Guydish J. R., Abramowtiz A., Woods W., Black D. M., Sorensen J. Changes in needle sharing behavior among intravenous drug users: San Francisco, 1986–1988. Am. J. Public Health 1990; 80: 995–997
  • Hahn R. A., Onorato I. M, Jones T. S., Dougherty J. Prevalence of HIV infection among intravenous drug users in the United States. JAMA 1989; 261: 2677–2684
  • Holmberg S. D. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am. J. Public Health 1996; 86: 642–654
  • Hopkins W. Needle sharing and street behavior in response to AIDS in New York City. Needle Sharing among Intravenous Drug Abusers: National and International Perspectives, R. J. Battjes, R. W. Pickens. Superintendent of Documents, US GPO, Washington, DC 1988; 18–27, [NIDA Research Monograph 80, DHHS Publication (ADM) 89–1567]
  • Johnson J., Williams M. A preliminary ethnographic decision tree model of injection drug users' needle sharing. Int. J. Addict. 1993; 28(10)997–1014
  • Jose B., Friedman S. R., Neaigus A., et al. Syringe-mediated drug-sharing (backloading): A new risk factor among injecting drug users. AIDS 1993; 7: 1653–1660
  • Kaplan E. H., O'Keefe E. Let the needles do the talking! Evaluating the New Haven needle exchange. Interfaces 1993; 23: 7–26
  • Klovdahl A. S. Social networks and the spread of infectious diseases: The AIDS example. Soc. Sci. Med. 1993; 21: 1203–1216
  • Koester S. Water, cookers, and cottons: Additional risks for intravenous drug abusers. In Community Epidemiology Work Group, Epidemiological Trends in Drug Abuse: Proceedings. National Institute on Drug Abuse, Rockville, MD 1989; III–118; III–120
  • Koester S. K. Copping, running, and paraphernalia laws: Contextual variables and needle risk behavior among injection drug users in Denver. Hum. Organ. 1994; 53(3)287–295
  • Koester S., Booth R., Wiebel W. The risk of HIV transmission from sharing water, drug mixing containers and cotton filters among intravenous drug users. Int. J. Drug Policy 1990; 1(3)28–30
  • Koester S., Booth R. E., Zhang Y. The prevalence of additional injection-related HIV risk behaviors among injection drug users. J. Acquired Immune Deficiency Syndromes Hum. Retroviol. 1996; 12(2)
  • Koester S., Hoffer L. Indirect sharing: Additional HIV risks associated with drug injection. AIDS Public Policy 1994; 9(2)100–105
  • The Collection and Interpretation of Data from Hidden Populations, E. Lambert. National Institute on Drug Abuse, Rockville, MD 1990, NIDA Research Monograph 98
  • Lambert E., Ashery R., Needle R. Qualitative Methods in Drug Abuse and HIV Research. National Institute on Drug Abuse, Rockville, MD 1995, NIDA Research Monograph 157
  • Latkin C., Mandell W., Vlahov D., Knowlton A., Oziemkowska M., Celentano D. Personal network characteristics as antecedents to needle sharing and shooting gallery attendance. Soc. Networks 1995; 17: 219–228
  • Lurie P., Reingold A. L. The Public Health Impact of Needle Exchange Programs in the United States and Abroad. Institute for Health Policy Studies, San Francisco, CA 1993
  • Marshall P. Ethical Dilemmas in Anthropological and Epidemiological Approaches to Prevention Research on Drug Abuse and HIV/AIDS. Paper presented at Integrating Anthropological Approaches in Epidemiological and Prevention Research on Drug Abuse and HIV/AIDS: Current Status and Future Prospects. National Institute on Drug Abuse. September 25, 1996
  • Neaigus A., Friedman S. R., Curtis R., Des Jarlais D. C., Furst R. T., et al. The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Soc. Sci. Med. 1994; 38(1)67–78
  • Social Networks, Drug Abuse, and HIV transmission, R. H. Needle, S. L. Coyle, S. G. Genser, R. T. Trotter. Superintendent of Documents, US GPO, Washington, DC 1995, NIDA Research Monograph 151, NIH Publication 95–3889
  • Normand J., Vlahov D., Moses L. Preventing HIV Transmission: The Role of Sterile Needles and Bleach. National Academy Press, Washington, DC 1995
  • Robertson J. R., Bucknall A. B. V., Welsby P. D., et al. Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers. Br. Med. J. 1986; 292: 527–529
  • Schoenbaum E. E., Hartel D., Selwyn P. A., et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. New Engl. J. Med. 1989; 321: 874–879
  • Shah S. M., Shapshak P., Rivers J. E., Stewart R. V., Weatherby N. L., et al. Detection of HIV-1 DNA in needles/syringes, paraphernalia, and washes from shooting galleries in Miami: A preliminary laboratory report. J. Acquired Immune Deficiency Syndromes Hum. Retroviol. 1996; 11(3)301–306
  • Siegal H. A., Carlson R. G., Falck R., Wang J. Injection drug users' needle-cleaning practices. Am. J. Public Health 1994; 84(9)1523–1524
  • Sotheran J. L., Friedman S. R., Clatts M. C., Des Jarlais D. C. Predictors of Injecting in Public Settings among NYC Injection Drug Users. Presented at the XI International Conference on AIDS. Vancouver, BC, Canada July, 1996; 7–12
  • SPSS FOR WINDOWS: PROFESSIONAL STATISTICS, RELEASE 6.0. 1993
  • Stephens R. C., Feucht T. E., Roman S. W. Effects of an intravenous program on AIDS-related drug and needle behavior among intravenous drug users. Am. J. Public Health 1991; 81: 568–571
  • Trotter R. T., Rothenberg R. B., Coyle S. Drug abuse and HIV prevention research: Expanding paradigms and network contributions to risk reduction. Connections 1995; 18(1)29–45
  • US GENERAL ACCOUNTING OFFICE. Needle Exchange Programs: Research Suggests Promise as an AIDS Prevention Strategy. Washington, DC 1993, GAO/HRD-93–60
  • Wasserman S., Faust K. Social Network Analysis: Methods & Applications. Cambridge University Press, Cambridge, MA 1994
  • Watters J. K. Historical perspective on the use of bleach in HIV/AIDS prevention. J. Acquired Immune Deficiency Syndromes 1994; 7: 743–746
  • Watters J. K., Downing M., Cose P., Lorvick J., Cheng Y.-T., Ferguson B. AIDS prevention for intravenous drug users in the community: Street-based education and risk behavior. Am. J. Community Psychol. 1990; 18: 587–596
  • Watters J. K., Estilo M. J., Clark G. L., Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 1994; 271: 115–120
  • Zule W. A. Risk and reciprocity: HIV and the injection drug user. J. Psychoactive Drugs 1992; 24(3)243–249

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.